David Altshuler, EVP, Global Research and CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,462 shares at $290.32 ($720K) on 2022-08-08, disclosed to the SEC on 2022-08-10.
Seasonal sale ($720k) by EVP, Global Research and CSO — this insider has traded VRTX in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $290.32 | 222 | $64K | 9.0% |
| 2 | $290.32 | 222 | $64K | 9.0% |
| 3 | $291.53 | 424 | $124K | 17.2% |
| 4 | $291.53 | 424 | $124K | 17.2% |
| 5 | $293.02 | 210 | $62K | 8.5% |
| 6 | $293.02 | 210 |
| $62K |
| 8.5% |
| 7 | $293.99 | 302 | $89K | 12.3% |
| 8 | $293.99 | 302 | $89K | 12.3% |
| 9 | $295.14 | 146 | $43K | 6.0% |
| Total | $292.38 avg | 2,462 | $720K | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-03-05 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $611K | — | Filing → |